3 Stocks Pulling The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading down today with the Dow Jones Industrial Average ( ^DJI) trading down 90 points (-0.6%) at 15,522 as of Tuesday, Aug. 6, 2013, 12:50 PM ET. The NYSE advances/declines ratio sits at 580 issues advancing vs. 2,389 declining with 97 unchanged.

The Health Services industry currently sits down 0.3% versus the S&P 500, which is down 0.6%. On the negative front, top decliners within the industry include Tenet Healthcare ( THC), down 4.4%, HCA Holdings ( HCA), down 2.3%, Boston Scientific ( BSX), down 1.1% and Aetna ( AET), down 0.7%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Mindray Medical International ( MR) is one of the companies pushing the Health Services industry lower today. As of noon trading, Mindray Medical International is down $0.85 (-2.0%) to $40.98 on heavy volume. Thus far, 722,058 shares of Mindray Medical International exchanged hands as compared to its average daily volume of 744,500 shares. The stock has ranged in price between $40.00-$42.20 after having opened the day at $41.39 as compared to the previous trading day's close of $41.83.

Mindray Medical International Limited, through its subsidiary, Shenzhen Mindray, develops, manufactures, and markets medical devices worldwide. It operates in three segments: Patient Monitoring and Life Support Products, In-Vitro Diagnostic Products, and Medical Imaging Systems. Mindray Medical International has a market cap of $4.8 billion and is part of the health care sector. Shares are up 27.9% year to date as of the close of trading on Monday. Currently there are 4 analysts that rate Mindray Medical International a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates Mindray Medical International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full Mindray Medical International Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

2. As of noon trading, Varian Medical Systems ( VAR) is down $0.81 (-1.1%) to $71.80 on light volume. Thus far, 269,373 shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 800,900 shares. The stock has ranged in price between $71.77-$72.82 after having opened the day at $72.57 as compared to the previous trading day's close of $72.61.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $7.9 billion and is part of the health care sector. Shares are up 3.4% year to date as of the close of trading on Monday. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and 2 rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance, growth in earnings per share and increase in net income. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Varian Medical Systems Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

1. As of noon trading, Zimmer Holdings ( ZMH) is down $0.81 (-1.0%) to $83.13 on average volume. Thus far, 445,126 shares of Zimmer Holdings exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $82.89-$83.88 after having opened the day at $83.77 as compared to the previous trading day's close of $83.94.

Zimmer Holdings, Inc., through its subsidiaries, engages in the design, development, manufacture, and marketing of orthopedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific. Zimmer Holdings has a market cap of $14.1 billion and is part of the health care sector. Shares are up 25.9% year to date as of the close of trading on Monday. Currently there are 10 analysts that rate Zimmer Holdings a buy, 1 analyst rates it a sell, and 15 rate it a hold.

TheStreet Ratings rates Zimmer Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Zimmer Holdings Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

3 Fallen Angels With Chart Appeal

3 Fallen Angels With Chart Appeal

3 Stocks Driving The Health Services Industry Higher

3 Stocks Driving The Health Services Industry Higher

Mindray Medical (MR) Stock Gains After Receiving 'Going Private' Proposal

Mindray Medical (MR) Stock Gains After Receiving 'Going Private' Proposal

Trade-Ideas: Mindray Medical International (MR) Is Today's Weak On High Relative Volume Stock

Trade-Ideas: Mindray Medical International (MR) Is Today's Weak On High Relative Volume Stock

Mindray Medical International (MR) Downgraded From Buy to Hold

Mindray Medical International (MR) Downgraded From Buy to Hold